Skip to main content

Table 5 Five- and ten-year overall survival and relapse-free survival according to co-expression patterns of nuclear IL4Rα and nuclear IL13Rα1

From: Expression of IL4Rα and IL13Rα1 are associated with poor prognosis of soft-tissue sarcoma of the extremities, superficial trunk, and retroperitoneum

Co-expression pattern of nIL4Rα and nIL13Rα1 No. 5y-OS (%) 10y-OS (%) 5y-RFS (%) 10y-RFS (%)
Co-expression Model 1
 nIL4Rα/nIL13Rα1, −/− 31 87 87 75 75
 nIL4Rα/nIL13Rα1,+/− 13 81 65 52 39
 nIL4Rα/nIL13Rα1, −/+ 9 67 36 22 11
 nIL4Rα/nIL13Rα1, +/+ 36 26 13 3 0
Co-expression Model 2
 nIL4Rα/nIL13Rα1, −/− 31 87 87 75 75
 nIL4Rα/nIL13Rα1, +/− or −/+ 22 75 50 40 27
 nIL4Rα/nIL13Rα1, +/+ 36 26 13 3 0
  1. Abbreviations: 5y-OS Overall survival rate at 5 years, 10y-OS Overall survival rate at 10 years, 5y-RFS Relapse-free survival rate at 5 years, 10y-RFS Relapse-free survival rate at 10 years, nIL4Rα Nuclear expression of IL4Rα, nIL13Rα1 Nuclear expression of IL13Rα1